Search

Pharmagest Interactive

Uždarymo kaina

0

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

Max

Pagrindiniai rodikliai

By Trading Economics

Pajamos

17M

Pardavimai

116M

P/E

Sektoriaus vid.

16.004

Dividendų pajamingumas

3.24

Pelno marža

14.879

Darbuotojai

1,400

EBITDA

116M

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

3.24%

Kitas uždarbis

2026-03-30

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

575M

Ankstesnė atidarymo kaina

0

Ankstesnė uždarymo kaina

0

Pharmagest Interactive Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-15 23:21; UTC

Įsigijimai, susijungimai, perėmimai

Qube Agrees to Takeover by MAM-Led Consortium Valuing Its Equity at $6.51 Billion

2026-02-15 23:45; UTC

Rinkos pokalbiai

Nikkei May Rise as Fears About AI Disruption Recede -- Market Talk

2026-02-15 23:40; UTC

Rinkos pokalbiai

Gold Falls on Possible Position Adjustments -- Market Talk

2026-02-15 23:06; UTC

Uždarbis

Thai Beverage: Spirits, Beer Businesses Posted Satisfactory EBITDA Growth, Alongside Profit Margin Expansion>Y92.SG

2026-02-15 23:04; UTC

Uždarbis

Thai Beverage 1Q Beer Business EBITDA THB4.64B, Up 4.7% on Year>Y92.SG

2026-02-15 23:04; UTC

Uždarbis

Thai Beverage 1Q Spirits Business EBITDA THB8.50B, Up 6.9% on Year >Y92.SG

2026-02-15 23:01; UTC

Uždarbis

Thai Beverage 1Q EBITDA THB16.75B, Up 1.8% on Year >Y92.SG

2026-02-15 23:01; UTC

Uždarbis

Thai Beverage 1Q FY Sales Revenue THB86.70B, Down 6.0% on Year>Y92.SG

2026-02-15 22:53; UTC

Įsigijimai, susijungimai, perėmimai

Qube: MAM-Led Offer Implies A$11.7 Billion Enterprise Value

2026-02-15 22:53; UTC

Įsigijimai, susijungimai, perėmimai

Qube: UniSuper to Transfer 15.07% Stake to Equivalent Ownership of Consortium Holding Structure

2026-02-15 22:52; UTC

Įsigijimai, susijungimai, perėmimai

Qube Shareholders to Receive A$5.20/Share in Cash

2026-02-15 22:52; UTC

Įsigijimai, susijungimai, perėmimai

Qube Holdings Agrees to Takeover by Macquarie Asset Management-Led Consortium

2026-02-15 22:22; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope CEO Tania Archibald Speaking on a Call With Media

2026-02-15 22:17; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope CEO: Stresses Whyalla Project Would Have to Make Sense to Shareholders

2026-02-15 22:16; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope CEO: Some Job Cuts Inevitable to Ensure Company is Competitive

2026-02-15 22:14; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope CEO: Higher Returns Tied to End of Capital Investment Program

2026-02-15 22:14; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Steel CEO: Higher Returns After Rebuffed Takeover Bid a 'Natural Coincidence'

2026-02-15 20:48; UTC

Uždarbis

BlueScope: Will Now Target Net Debt of Up to A$1.5 Billion; Will Surpass as Needed

2026-02-15 20:47; UTC

Uždarbis

BlueScope: Expects Full Benefits of Further A$150M Cost Savings in FY 2027

2026-02-15 20:46; UTC

Uždarbis

BlueScope: Recorded Net Annualized Cost Improvements of A$190 Million in 1H

2026-02-15 20:45; UTC

Uždarbis

BlueScope Expects a One-Third Lower 2H Result From Asia Business Vs 1H

2026-02-15 20:44; UTC

Uždarbis

BlueScope Expects 15% Higher 2H Result From North America Business Vs 1H

2026-02-15 20:44; UTC

Uždarbis

BlueScope Expects Lower 2H Result From Australia Business Vs 1H

2026-02-15 20:43; UTC

Uždarbis

BlueScope Expects 2H Underlying Ebit of A$620 Million-A$700 Million

2026-02-15 20:42; UTC

Uždarbis

BlueScope Net Debt A$2.2 Million at Dec. 31

2026-02-15 20:42; UTC

Uždarbis

BlueScope 1H Underlying Ebit A$557.5 Million, Up 81% On-Year

2026-02-15 20:41; UTC

Uždarbis

BlueScope 1H Underlying Ebitda A$915.3 Million, Up 39% On-Year

2026-02-15 20:40; UTC

Uždarbis

BlueScope 1H Underlying Profit A$382.0 Million Vs A$176.4 Million Year Prior

2026-02-15 20:40; UTC

Uždarbis

BlueScope 1H Sales Revenue From Continuing Ops A$8.22 Billion, Up 4% On-Year

2026-02-15 20:39; UTC

Uždarbis

BlueScope Intends to Spend A$310 Million on Buyback, Or Other Returns if Share Repurchases Limited

Pharmagest Interactive Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

0

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Pharmagest Interactive

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
help-icon Live chat